Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
BioVie Day webinar is March 23, 2023 at 10:00 am ET
https://feeds.issuerdirect.com/news-release.html?newsid=8012584249565549
BioVie: Update On Alzheimer's And Parkinson's Programs, And Focus On Its Treatment For Refractory Ascites
https://seekingalpha.com/article/4587473-biovie-update-on-alzheimers-and-parkinsons-programs-and-focus-on-its-treatment-for-refractory-ascites
*****
Have you seen this?
Epalinges, Switzerland, March 24, 2022 - Mymetics Corporation (OTCQB: MYMX), a pioneer in the research and development of virosome based vaccines and immunotherapies against human life disabling and infectious diseases, announced today a publication in Nature Scientific Reports in collaboration with the AMC – Amsterdam University Medical Center, with title: “A SARS-CoV-2 Wuhan spike virosome vaccine induces superior neutralization breadth compared to one using the Beta spike”.
https://www.mymetics.com/media-center/
2 consecutive scientific publication this year seems catches some attention on MYMX. Cheers!
regards,
Finally Published!
Cooperation Between Systemic and Mucosal Antibodies Induced by Virosomal Vaccines Targeting HIV-1 Env: Protection of Indian Rhesus Macaques Against Low-Dose Intravaginal SHIV Challenges
Funding
This work was supported by the Bill & Melinda Gates Foundation Grant OPP1111654 to RMR, NIH U19 AI142636 to RMR and SF, Collaboration for AIDS Vaccine Discovery, Vaccine Immune Monitoring Center (CAVIMC) grant OPP1146996, the National Institutes of Health/Office of Research Infrastructure Programs (NIH/ORIP) Grant P51 OD011133 to the Southwest National Primate Research Center (SNPRC) in San Antonio, TX, and National Institute of Allergy and Infectious Diseases (NIAID, Duke Center for AIDS Research (CFAR) grant P30 AI064518.
https://www.frontiersin.org/articles/10.3389/fimmu.2022.788619/full
>>> RMR - Ruth M. Rupretch, SF - Sylvain Fleury
regards,
Finally Published!
Cooperation Between Systemic and Mucosal Antibodies Induced by Virosomal Vaccines Targeting HIV-1 Env: Protection of Indian Rhesus Macaques Against Low-Dose Intravaginal SHIV Challenges
Funding
This work was supported by the Bill & Melinda Gates Foundation Grant OPP1111654 to RMR, NIH U19 AI142636 to RMR and SF, Collaboration for AIDS Vaccine Discovery, Vaccine Immune Monitoring Center (CAVIMC) grant OPP1146996, the National Institutes of Health/Office of Research Infrastructure Programs (NIH/ORIP) Grant P51 OD011133 to the Southwest National Primate Research Center (SNPRC) in San Antonio, TX, and National Institute of Allergy and Infectious Diseases (NIAID, Duke Center for AIDS Research (CFAR) grant P30 AI064518.
https://www.frontiersin.org/articles/10.3389/fimmu.2022.788619/full
regards,
Remember him?
Athira Pharma Announces Appointment of Grant Pickering to its Board of Directors
"Mr. Pickering is Chief Executive Officer, co-founder and member of the Board of Directors at Vaxcyte, Inc. (NASDAQ: PCVX), a vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases"
"Mr. Pickering previously served as CEO of Mymetics Corporation and Juvaris BioTherapeutics. Prior to Juvaris, Mr. Pickering served as Senior Vice President, Operations at Dendreon Corporation and led marketing and business development for Algos Pharmaceutical Corporation. Mr. Pickering began his career at Glaxo and Johnson & Johnson in sales, marketing, and clinical research roles. Mr. Pickering earned his BS degree in marketing from The Pennsylvania State University and his MBA from Georgetown University with high honors"
https://finance.yahoo.com/news/athira-pharma-announces-appointment-grant-120000088.html
One has to wonder where Mymetics stands should he be still our CEO today.
https://xconomy.com/san-francisco/2012/04/11/mymetics-ropes-in-dendreon-kpcb-vets-to-restart-vaccine-developer/
regards,
Still here buddy. I ain't going anywhere. Been here since 2010. Patiently waiting. Nice stock movement today :))
MYMX long!
regards,
I may not have posting for a while but always checking the board at spare times. Gladly that you and other long fellows here are keeping up the dd's that keeping us informed. Greatly appreciated! You are right! We are all waiting for Mr. Kempers to make the right move moving forward.
best regards Longs.
Hmmmm....that's weird.
That is why the dynamic duo, Grant Pickering (now CEO of Vaxcyte) and Dr. Christopher Henney (Co-founder and Chairman of Dendreon Corp) left in less than a year. The stock would have been trading in a major exchange in multiple dollars now. :(
https://xconomy.com/san-francisco/2012/04/11/mymetics-ropes-in-dendreon-kpcb-vets-to-restart-vaccine-developer/
The manipulator/s is trying to test our nerves. Good luck with that!
STAY STRONG Folks!
later
Oh okay. Darn manipulators!
Cantor Fitzgerald? Is this the company well known for shorting???
hmmmm... who is BGCE???
Is MYMX qualified for Reddit? I heard this guys love killing shorts.
Time will tell Bow-tie. Patience man!
I see... Thanks!
I'm at work and my account is showing MYMX -$43000. What happened? I checked and nothing negative as far as news and SEC filings. Anyway, been holding and accumulating since 2010 and NO WAY I'm giving up a single share at a huge discount!.
MYMX LONG & STRONG!
regards,
Happy New Year Fellows! May this new year kicks in with a big bonanza surprise !
Looking forward when MYMX announces a Cold Chain Independent Thermostable Intra-nasal/sublingual Covid Vaccine in partnership with a major pharmaceutical company. When this happens MYMX will blow up exponentially.
WOW!!! Great find. Oh my! MYMX co-owned IP with Catalent. This just sweeten our relationship with one of the world's top CMOs. This just strengthen MYMX as potential M&A target. Thank you... awesome DD!!!
Patent History
Publication number: 20200170933
Type: Application
Filed: Nov 26, 2019
Publication Date: Jun 4, 2020
Applicants: Catalent U.K. Swindon Zydis Limited (Swindon), Mymetics Corporation (Epalinges)
Inventors: Yik Teng WONG (Wiltshire), Charli SMARDON (Wiltshire), Khojasteh SHIRKHANI (Swindon), Mario AMACKER (Schmitten), Sylvain FLEURY (Bottens), Antonius Johannes Henrikus STEGMANN (TZ Rijnsburg)
Application Number: 16/696,752
Impatient sellers will regret big time. MYMX will rise exponentially!!! This is being accumulated as covid vaccine news is imminent. imo
Just giving motivation to those buyers down there too bad it ain't gonna happen this time. LOL Monster run ahead?
Fellow Longs >>> AIM HIGH... keeps pps STAY HIGH !!!
LONG & $TRONG ***MYMX***
HAPPY THANKSGIVING Everyone!!!
Gotta pay up to get those shares. Not happening there. lol... CDEL(813,000 @.047), GTSM(105,250 @.043)
Cold Chain issues? MYMX got the solution!
https://cordis.europa.eu/docs/results/h2020/646/646122_PS/maciviva-project-concept.jpg
MORE DETAILS HERE for newbies in the house:
https://cordis.europa.eu/search?q=%27maciviva%27&p=1&num=10&srt=Relevance:decreasing
Yup! Just heating up...
Yeah bud! as long as we're counting million$$$. lol
Yeah. This gem is way under-the-radar. Just a matter of being noticed but not any longer, imo.
Wow! NEWS!!! Keep it rollin' Mr. K!
One stellar news and we fly exponentially. Just a matter of being noticed now.
Funny thing, with all these vaccine cold chain logistic issues going around and this gem is still unnoticed? Mr. Kempers this is the time to step up and get the attention we are all longing for! We got the solution to this and we all know it.
Wow! we got some volume. News coming?
Come on... Mr. K. Don't let them beat us. But surprisingly, Dr. Hotez is in the article?
Nasal Spray Prevents COVID Infection in Ferrets, Study Finds
A nasal spray that blocks the absorption of the SARS-CoV-2 virus has completely protected ferrets it was tested on, according to a small study released Thursday by an international team of scientists. The study, which was limited to animals and has not yet been peer-reviewed, was assessed by several health experts at the request of The New York Times.
The lipoprotein can be inexpensively produced as a freeze-dried white powder that does not need refrigeration, Moscona said. A doctor or pharmacist could mix the powder with sugar and water to produce a nasal spray.
Dr. Peter J. Hotez, dean of the National School of Tropical Medicine at Baylor College of Medicine, said the therapy looked “really promising.”
https://news.yahoo.com/nasal-spray-prevents-covid-infection-131011519.html
>>>"mix the powder with sugar and water to produce a nasal spray"???. We don't do that here! lol... try MYMX' DIRECT ADMINISTERING WITHOUT Reconstitution!!!
Have a good weekend!
regards,
Come on... Mr. Kempers this is our expertise!!! Inhaled Vaccines Aim to Fight Coronavirus at Its Point of Attack
“The first generation of vaccines are probably going to protect a lot of people,” said Michael Diamond, an infectious disease specialist at Washington University in St. Louis. “But I think it’s the second- and third-generation vaccines — and maybe intranasal vaccines will be a key component of this — that ultimately are going to be necessary. Otherwise, we’ll continue to have community transmission.”
https://www.bloomberg.com/news/articles/2020-10-11/covid-19-inhaled-vaccines-may-be-more-effective-than-injections
You're right! If this happens, its a breakthrough - GAME CHANGER!
We all know how he does things for long now. Hoping he's shifting things for a change.
Whoa! Where did you find this info? This would be a game-changer!
"Wait mymx using the 3 second lozenges under the tongue for Covid Vaccine with Baylor!! :) For poor countries, Can be shipt in a box".
Good Morning folks! MYMX looking good! Finally got an update from Mr. Kempers. More waves of news to come per pr.
Hold Long & Strong!
regards,